Answers are grounded in this paper and cite their sources.
Itolizumab in addressing symptoms of acute respiratory distress syndrome (ARDS) with weaning off oxygen requirements in a COVID-19 patient: A case study - IJIRM- Print ISSN No: - 2581-4214 Online ISSN No:- 2581-4222 Article DOI No:- 10.18231/j.ijirm.2021.013, IP Indian Journal of Immunology and Respiratory Medicine-IP
No takes yet. Share an insight, caveat, or question.
Thacker et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: